IL157926A - Peptides for the diagnosis of schizophrenia - Google Patents

Peptides for the diagnosis of schizophrenia

Info

Publication number
IL157926A
IL157926A IL157926A IL15792603A IL157926A IL 157926 A IL157926 A IL 157926A IL 157926 A IL157926 A IL 157926A IL 15792603 A IL15792603 A IL 15792603A IL 157926 A IL157926 A IL 157926A
Authority
IL
Israel
Prior art keywords
schizophrenia
peptides
diagnosis
Prior art date
Application number
IL157926A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14215901A external-priority patent/IL142159A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL157926A priority Critical patent/IL157926A/en
Publication of IL157926A publication Critical patent/IL157926A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL157926A 2001-03-21 2003-09-15 Peptides for the diagnosis of schizophrenia IL157926A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL157926A IL157926A (en) 2001-03-21 2003-09-15 Peptides for the diagnosis of schizophrenia

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27865901P 2001-03-21 2001-03-21
IL14215901A IL142159A0 (en) 2001-03-21 2001-03-21 Novel peptides for the diagnosis of schizophrenia
PCT/IL2002/000233 WO2002074793A2 (fr) 2001-03-21 2002-03-21 Nouveaux peptides permettant le diagnostic de la schizophrenie
IL157926A IL157926A (en) 2001-03-21 2003-09-15 Peptides for the diagnosis of schizophrenia

Publications (1)

Publication Number Publication Date
IL157926A true IL157926A (en) 2010-12-30

Family

ID=26324018

Family Applications (1)

Application Number Title Priority Date Filing Date
IL157926A IL157926A (en) 2001-03-21 2003-09-15 Peptides for the diagnosis of schizophrenia

Country Status (7)

Country Link
US (1) US7354991B2 (fr)
EP (1) EP1415162B1 (fr)
JP (2) JP5048205B2 (fr)
AU (1) AU2002241232B2 (fr)
CA (1) CA2441925C (fr)
IL (1) IL157926A (fr)
WO (1) WO2002074793A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008016064A1 (de) * 2008-03-26 2009-10-01 Carsten Dr. Korth Verfahren zur Diagnose und Behandlung von chronisch psychiatrischen Erkrankungen sowie Marker und Targets für solche Verfahren
IL256880B2 (en) * 2015-07-14 2024-03-01 Yeda Res & Dev Combining proteins for the diagnosis of schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429929A (en) 1991-04-19 1995-07-04 The Trustees Of Columbia University In The City Of New York Method for detecting antibodies to a neuroblastoma antigen in mental illness
IL107515A (en) 1993-11-05 1997-01-10 Yeda Res & Dev Diagnosis of mental disorders
US6008001A (en) 1993-11-05 1999-12-28 Yeda Research And Development Co. Ltd. Diagnosis of the susceptibility of contracting schizophrenia
WO1995023970A1 (fr) 1994-03-01 1995-09-08 Yeda Research And Development Co. Ltd. Essai destine au diagnostic de la schizophrenie
IL122490A0 (en) 1997-12-07 1998-06-15 Yeda Res & Dev Assay for schizophrenia based on skin reaction
JP4364433B2 (ja) * 1998-04-02 2009-11-18 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド 新規なペプチドに基づく精神分裂病の診断のためのアッセイ
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines

Also Published As

Publication number Publication date
WO2002074793A2 (fr) 2002-09-26
CA2441925C (fr) 2012-07-31
JP5048205B2 (ja) 2012-10-17
CA2441925A1 (fr) 2002-09-26
US20050089927A1 (en) 2005-04-28
JP2009221225A (ja) 2009-10-01
EP1415162B1 (fr) 2011-05-11
AU2002241232B2 (en) 2007-02-01
WO2002074793A3 (fr) 2004-02-26
US7354991B2 (en) 2008-04-08
JP2004533420A (ja) 2004-11-04
EP1415162A2 (fr) 2004-05-06

Similar Documents

Publication Publication Date Title
IL159310A0 (en) Peptide-based compounds
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HK1090292A1 (en) Compounds effecting glukokinase
EP1359830A4 (fr) Baguettes a riz de type pinces
EP1352661A4 (fr) Injections destinees a une endoscopie
IL162385A0 (en) Process for the preparation of echinocandin derivatives
IL150600A0 (en) Process for the preparation of peptides
GB0100196D0 (en) Peptides
GB0120658D0 (en) Medical aerosols
GB0216884D0 (en) Diagnostic marker
IL158742A0 (en) Peptides for use as translocation factors
PL366425A1 (en) Peptide compounds
IL157926A (en) Peptides for the diagnosis of schizophrenia
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
EP1419428A4 (fr) Strategie basee sur des ensembles permettant d'elaborer des produits pharmaceutiques a base de proteines
GB0109438D0 (en) Peptides
SG100673A1 (en) Arrangement for abacus-like calculation
EP1578908A4 (fr) Gene humain de la schizophrenie
IL142159A0 (en) Novel peptides for the diagnosis of schizophrenia
IL157926A0 (en) Novel peptides for the diagnosis of schizophrenia
GB0103517D0 (en) Polypeptide
GB0427771D0 (en) Diagnostic marker
GB0108587D0 (en) Diagnosis
GB0202562D0 (en) Diagnosis

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed